Drug Shortage Report for JAMP OLANZAPINE FC
| Report ID | 165921 |
| Drug Identification Number | 02417286 |
| Brand name | JAMP OLANZAPINE FC |
| Common or Proper name | Olanzapine Tablets - Manufacturer’s Standard |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | OLANZAPINE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N05AH |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-08-01 |
| Estimated end date | 2023-10-31 |
| Actual end date | 2023-09-14 |
| Shortage status | Resolved |
| Updated date | 2023-09-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.